Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Disis

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|January 5, 2002
Cancer vaccines targeting the HER2/neu oncogenic proteinM L Disis, K Schiffman
Clinical Lung Cancer|January 21, 2004
HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancersK Schiffman, M L Disis
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Issues on clinical applications of cancer vaccinesM L Disis, K Schiffman
Clinical Breast Cancer|March 20, 2002
Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccineK L Knutson, M L Disis
Critical Reviews in Immunology|January 7, 1998
HER-2/neu oncogenic protein: issues in vaccine developmentM L Disis, M A Cheever
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2000
Tumor vaccines for the management of prostate cancerD G McNeel, M L Disis
Current Opinion in Immunology|October 1, 1996
Oncogenic proteins as tumor antigensM L Disis, M A Cheever
Advances in Cancer Research|January 1, 1997
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancerM L Disis, M A Cheever
Clinical and Experimental Immunology|January 24, 2004
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansionK L Knutson, M L Disis
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 27, 2005
Augmenting T helper cell immunity in cancerK L Knutson, M L Disis
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|January 5, 2002
Cancer vaccines targeting the HER2/neu oncogenic proteinM L Disis, K Schiffman
Clinical Lung Cancer|January 21, 2004
HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancersK Schiffman, M L Disis
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Issues on clinical applications of cancer vaccinesM L Disis, K Schiffman
Clinical Breast Cancer|March 20, 2002
Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccineK L Knutson, M L Disis
Critical Reviews in Immunology|January 7, 1998
HER-2/neu oncogenic protein: issues in vaccine developmentM L Disis, M A Cheever
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2000
Tumor vaccines for the management of prostate cancerD G McNeel, M L Disis
Current Opinion in Immunology|October 1, 1996
Oncogenic proteins as tumor antigensM L Disis, M A Cheever
Advances in Cancer Research|January 1, 1997
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancerM L Disis, M A Cheever
Clinical and Experimental Immunology|January 24, 2004
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansionK L Knutson, M L Disis
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 27, 2005
Augmenting T helper cell immunity in cancerK L Knutson, M L Disis
Pageof 5